PharmCIS, developed by Fivium, for the Department of Health, supports the nationwide approval, pricing and listing of medicines on the Australian Pharmaceutical Benefits Scheme (PBS).
The system processes and tracks industry submissions for the PBS and supports workflow stages including:
- Validation of submissions
- Evaluation of economical, clinical, demographic and financial information
- Committee collaboration and information distribution
- Price negotiation
- Subsidy approvals
- Publishing and listing a drug on the PBS. This includes output to a standardised data format (PBSXML) for integration across the industry
PharmCIS caters for ongoing changes in policy and legislation. This includes recent chemotherapy drug measures, price disclosure and price calculator functionality.
The system allows the government to track savings anticipated from recent policy reforms. As part of these reforms, it is expected to deliver $1.9 billion in health savings for taxpayers over five years through price disclosure and other price reduction initiatives.
PharmCIS is also an early adopter of the Australian Medicines Terminology which is a national implementation based on the international SNOMED Clinical Terminology. This is a key step change towards the new eHealth records project.
It contains a comprehensive source of information such as industry standard medicine definitions including detailed composition information, subsidies, restrictions and prescribing rules - a fundamental building block for ePrescribing. Advanced searching and high accessibility to this information is also available.